TrivarXMDBIF Days Payable is 0.00 as of Dec. 2025. The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, TrivarX ranks worse than 164744.48% on this metric.
The historical rank and industry rank for TrivarX's Days Payable or its related term are showing as below:
During the past 13 years, TrivarX's highest Days Payable was 321565.00. The lowest was 1813.69. And the median was 2097.15.
MDBIF's Days Payable is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 58.16 * Ranked among companies with meaningful Days Payable only.
TrivarX's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
TrivarX Days Payable Related Terms
TrivarX Days Payable Historical Data
* Premium members only.
The historical data trend for TrivarX's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, TrivarX's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TrivarX Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Days Payable distribution charts can be found below:
* The bar in red indicates where TrivarX's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TrivarX's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TrivarX (MDBIF) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TrivarX and its competitors. Over the past decade, TrivarX's Days Payable has ranged from 1,813.69 to 321,565.00. According to the industry distribution chart, TrivarX ranks #999999 out of 607 companies in the Healthcare Providers & Services industry.
Is TrivarX's Days Payable too high?
TrivarX's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 1,813.69 to a high of 321,565.00. Based on the distribution chart, TrivarX ranks #999999 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does TrivarX's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, TrivarX ranks #999999 out of 607 companies for Days Payable. This places TrivarX in the lower half of its industry. The industry median Days Payable is 58.16. Historically, TrivarX's own Days Payable has ranged from 1,813.69 to 321,565.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TrivarX and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TrivarX's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TrivarX stock overvalued right now?
Based on GuruFocus' analysis, TrivarX (MDBIF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.00 — trading 94.8% below its estimated fair value. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TrivarX (MDBIF), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability. The Company has one operating segment, being the research, development and commercialisation of its software asaService product, and two geographical locations, being Australia and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDBIF has been successfully added to your 